Albert Seymour - See Remarks, Homology Medicines, Inc

As of April 21, 2022


What is Albert Seymour's Net Worth?

The current estimated net worth of Homology Medicines, Inc's See Remarks, Albert Seymour, is estimated to be about $1.92M . Albert Seymour owns about 131,646 units of Homology Medicines, Inc common stock. In the last 4 years at Homology Medicines, Inc, Albert Seymour has sold an estimated value of $1.65M worth.

What is Albert Seymour's Past Insider Trading?

Albert Seymour's largest sale order was 18,600 units , worth over $300.36K on December 3, 2019. In total, Albert Seymour has made about 16 transactions over 4 years of their time at Homology Medicines, Inc. Albert Seymour usually trades in January, with the busiest year in 2019. The most recent transaction was a sale order of 1,661 units , worth over $6.28K on January 12, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Albert Seymour's Salary in 2020?

As See Remarks of Homology Medicines, Inc, Albert Seymour has a total base salary of $426,800 . Albert Seymour received compensation valued at about $607,577 in 2020 after becoming See Remarks. The vast majority of their compensation came in the form of other earnings, plans or compensations of $170,720 , and other compensation of $10,057 .

What is Albert Seymour's' Mailing Address?

  • Mailing address is C/o Homology Medicines, Inc. One Patriots Park Bedford MA 01730 MA

Homology Medicines, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Arthur O. Tzianabos, Ph.D. 2020 $563,200 - - $309,760 $13,000 $885,960
Arthur O. Tzianabos, Ph.D. 2019 $537,600 - $4,217,097 $295,680 $12,500 $5,062,877
Albert Seymour, Ph.D. 2020 $426,800 - - $170,720 $10,057 $607,577
Albert Seymour, Ph.D. 2019 $405,600 - $1,295,756 $162,240 $13,231 $1,876,827
W. Bradford Smith 2020 $406,700 - - $162,680 $13,000 $582,380
W. Bradford Smith 2019 $384,200 - $1,307,536 $153,680 $14,880 $1,860,296
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1661998/000156459021021931/fixx-def14a_20210617.htm

What are Homology Medicines, Inc's Past Insider Trades?

Homology Medicines, Inc's most recent insider trade came on January 12, 2022 by W. Bradford Smith who sold 2,182 units worth $8.25K . In the last 4 years, insiders at Homology Medicines, Inc have sold an estimated value of $109.51M and bought an estimated value of $60.18M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Albert Seymour, See Remarks,  Timothy P Kelly, Chief Operating Officer,  and Arthur Tzianabos, President & CEO .

Homology Medicines, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1